Literature DB >> 20225034

New protocol for lentiviral vector mass production.

María Mercedes Segura1, Alain Garnier, Yves Durocher, Sven Ansorge, Amine Kamen.   

Abstract

Multiplasmid transient transfection is the most widely used technique for the generation of lentiviral vectors. However, traditional transient transfection protocols using 293 T adherent cells and calcium phosphate/DNA co-precipitation followed by ultracentrifugation are tedious, time-consuming, and difficult to scale up. This chapter describes a streamlined protocol for the fast mass production of lentiviral vectors and their purification by affinity chromatography. Lentiviral particles are generated by transient transfection of suspension growing HEK 293 cells in serum-free medium using polyethylenimine (PEI) as transfection reagent. Lentiviral vector production is carried out in Erlenmeyer flasks agitated on orbital shakers requiring minimum supplementary laboratory equipment. Alternatively, the method can be easily scaled up to generate larger volumes of vector stocks in bioreactors. Heparin affinity chromatography allows for selective concentration and purification of lentiviral particles in a singlestep directly from vector supernatants. The method is suitable for the production and purification of different vector pseudotypes.

Entities:  

Mesh:

Year:  2010        PMID: 20225034     DOI: 10.1007/978-1-60761-533-0_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Production of lentiviral vectors for transducing cells from the central nervous system.

Authors:  Mingjie Li; Nada Husic; Ying Lin; B Joy Snider
Journal:  J Vis Exp       Date:  2012-05-24       Impact factor: 1.355

Review 2.  Progress and challenges in viral vector manufacturing.

Authors:  Johannes C M van der Loo; J Fraser Wright
Journal:  Hum Mol Genet       Date:  2015-10-30       Impact factor: 6.150

Review 3.  Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies.

Authors:  X Wang; I Rivière
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

4.  Efficient large volume lentiviral vector production using flow electroporation.

Authors:  Scott R Witting; Lin-Hong Li; Aparna Jasti; Cornell Allen; Kenneth Cornetta; James Brady; Rama Shivakumar; Madhusudan V Peshwa
Journal:  Hum Gene Ther       Date:  2011-10-24       Impact factor: 5.695

5.  Production, purification and titration of a lentivirus-based vector for gene delivery purposes.

Authors:  Masoud Nasri; Ali Karimi; Mehdi Allahbakhshian Farsani
Journal:  Cytotechnology       Date:  2014-03-06       Impact factor: 2.058

6.  Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells.

Authors:  Arash Nanbakhsh; Brad Best; Matthew Riese; Sridhar Rao; Li Wang; Jeffrey Medin; Monica S Thakar; Subramaniam Malarkannan
Journal:  J Vis Exp       Date:  2018-01-15       Impact factor: 1.355

7.  Development of a laboratory scalable process for enhancing lentivirus production by transient transfection of HEK293 adherent cultures.

Authors:  Y K Ho; H P Too
Journal:  Gene Ther       Date:  2020-04-27       Impact factor: 5.250

8.  A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytes.

Authors:  Shicheng Yang; Neel K Karne; Stephanie L Goff; Mary A Black; Hui Xu; Daniela Bischof; Kenneth Cornetta; Steven A Rosenberg; Richard A Morgan; Steven A Feldman
Journal:  Hum Gene Ther Methods       Date:  2012-04-19       Impact factor: 2.396

9.  Optimization of lentiviral vector production using polyethylenimine-mediated transfection.

Authors:  Yong Tang; Kenneth Garson; Li Li; Barbara C Vanderhyden
Journal:  Oncol Lett       Date:  2014-11-07       Impact factor: 2.967

10.  LentiPro26: novel stable cell lines for constitutive lentiviral vector production.

Authors:  H A Tomás; A F Rodrigues; M J T Carrondo; A S Coroadinha
Journal:  Sci Rep       Date:  2018-03-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.